Answers are grounded in this paper and cite their sources.
Thymic carcinoma is a rare cancer type with limited treatment options. Our previous study demonstrated that statins, which inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase, can prevent thymic carcinoma. However, the mechanisms through which statins affect intracellular events in cancer cells are not well understood. The aim of the study was to determine how thymic carcinoma modulates the intracellular signals in response to statin administration.
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: